Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized TrialsSabino De Placido, Giuseppe Cancello, Diego D’Agostino et al.|Journal of Clinical Oncology|2007Cited by 413
Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trialLucia Del Mastro, Francesco Cognetti, Cecilia Nisticò et al.|The Lancet|2015Cited by 201
Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational studyGiuseppe Buono, Grazia Arpino, Anna Crispo et al.|Breast Cancer Research and Treatment|2020Cited by 70
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trialLucia Del Mastro, A Parisi, Francesca Poggio et al.|The Lancet Oncology|2022Cited by 50
Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapyGrazia Arpino, Sabino De Placido, Carmine De Angelis et al.|Breast Cancer Research and Treatment|2015Cited by 49